Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Russian launch for GMDP

Sep. 6, 1996

Abbott describes immunosuppressants

Sep. 6, 1996

Interferon production enhancer discovered by Japanese researchers

Sep. 6, 1996

New agents for use in transplantation

Aug. 30, 1996

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

STV: Possible antituberculosis and autoimmune disease therapy

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Cel-Sci and U.S. Navy collaborate on malaria vaccine

Aug. 23, 1996

North American Vaccine/Abbott DTaP marketing agreement

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...